The effects of Brazilian chitosan-based biomaterials on wound healing in rats

Preparation of nanocomposite based on chitosan-PDCOEMA containing biosynthesized ZnO: Biological and thermal characterization

In this study, poly(2-(3,5-dichloroanilino)-2-oxoethyl 2-methylprop-2-enoate) (PDCOEMA), a new synthetic polymer based on methacrylate, was synthesized and characterized. The blend of PDCOEMA with chitosan (CS) was prepared by the hydrothermal method and the DSC technique confirmed its formation. It was observed that PDCOEMA increased the thermal stability and glass transition temperature (Tg) of CS. The Tg value of the PDCOEMA-CS blend was increased at about 7 °C with the highest ZnO NPs contribution rate. PDCOEMA-CS/ZnO nanocomposites were prepared by adding ZnO NPs produced by biosynthesis at different weight ratios to the PDCOEMA-CS blend by hydrothermal method. When the thermal stability of nanocomposites determined by TGA was examined, it was observed that it increased significantly compared to CS. While the initial decomposition temperature of CS was 270 °C, this value increased to 293 °C after blending with DCOEMA, and to 317 °C with the addition of 7 % ZnO NPs. Antimicrobial, anticancer, cytotoxic, antioxidant, and wound healing properties of PDCOEMA, CS, PDCOEMA-CS blend, and nanocomposites were determined. According to the obtained results, it was observed that nanocomposites containing 5 % and 7 % ZnO NPs showed good anticancer activity against A549 cells at a dose of 10 μg/mL. The results show that the produced nanocomposites can contribute to developing CS-based materials.

Dose-Effect Relationship of Chitosan and Danshen Combined Injection for Fallopian Tube Recanalization

Objectives: This study examined the dose-effect relationship of chitosan and danshen combined injections on the long-term prevention of fallopian tube re-obstructions, with increased pregnancy rates in infertile women.

Methods: High-performance liquid chromatography was used to determine the content changes of combined chitosan and danshen injection. Two hundred and eighty patients with fallopian tube obstructions were randomly assigned to four groups. Group A (control group, saline), Group B (2 ml chitosan, 4 ml danshen), Group C (2 ml chitosan, 10 ml danshen), and Group D (1 ml chitosan, 10 ml danshen). Injections were administered after tubal recanalization.

Results: The effective constituent of chitosan and danshen injection was stable. Tubal patency rate was 94.2% and 87.3% in Group C after 1 and 3 years, respectively, which was significantly higher than Groups A (38.6%, 31.5%), B (73.5%, 64.1%), and D (68.5%, 50.7%). Intrauterine pregnancy rates were 61.8% and 79.4% in Group C after 1 and 3 years, respectively, and were significantly higher than Groups A (31.8%, 34.8%), B (40.1%, 62.5%), and D (38.5%, 58.5%) (p < 0.05).

Conclusion: Combined Chitosan and danshen injections prevented tubal obstruction and increased pregnancy rates for long periods using an optimal ratio of 1 part chitosan and 5 parts danshen.